This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Takeuchi, H. Articles by Kondo, S. Search for Related Content PubMed PubMed Citation Articles by Takeuchi, H. Articles by Kondo, S.

Synergistic Augmentation of Rapamycin-Induced Autophagy in Malignant Glioma Cells by Phosphatidylinositol 3-Kinase/Protein Kinase B Inhibitors

Departments of ¹ Neurosurgery and ² Molecular Therapeutics, University of Texas M.D. Anderson Cancer Center and ³ University of Texas Graduate School of Biomedical Science at Houston, Houston, Texas

Requests for reprints: Seiji Kondo, Department of Neurosurgery, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 64, Houston, TX 77030. Phone: 713-792-3526; Fax: 713-794-5514; E-mail: seikondo{at}mdanderson.org.

The mammalian target of rapamycin (mTOR) is a downstream effector of the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway and a central modulator of cell proliferation in malignant gliomas. Therefore, the targeting of mTOR signaling is considered a promising therapy for malignant gliomas. However, the mechanisms underlying the cytotoxic effects of a selective mTOR inhibitor, rapamycin, on malignant glioma cells are poorly understood. The purpose of this study was thus to elucidate how rapamycin exerts its cytotoxic effects on malignant glioma cells. We showed that rapamycin induced autophagy but not apoptosis in rapamycin-sensitive malignant glioma U87-MG and T98G cells by inhibiting the function of mTOR. In contrast, in rapamycin-resistant U373-MG cells, the inhibitory effect of rapamycin was minor, although the phosphorylation of p70S6 kinase, a molecule downstream of mTOR, was remarkably inhibited. Interestingly, a PI3K inhibitor, LY294002, and an Akt inhibitor, UCN-01 (7-hydroxystaurosporine), both synergistically sensitized U87-MG and T98G cells as well as U373-MG cells to rapamycin by stimulating the induction of autophagy. Enforced expression of active Akt in tumor cells suppressed the combined effects of LY294002 or UCN-01, whereas dominant-negative Akt expression was sufficient to increase the sensitivity of tumor cells to rapamycin. These results indicate that rapamycin exerts its antitumor effect on malignant glioma cells by inducing autophagy and suggest that in malignant glioma cells a disruption of the PI3K/Akt signaling pathway could greatly enhance the effectiveness of mTOR inhibitors.

This article has been cited by other articles:

				J. Fu, C.-J. Shao, F.-R. Chen, H.-K. Ng, and Z.-P. Chen Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines Neuro Oncology, October 15, 2009; (2009) nop005v1. [Abstract] [Full Text] [PDF]

				H. Zhang, X. Kong, J. Kang, J. Su, Y. Li, J. Zhong, and L. Sun Oxidative Stress Induces Parallel Autophagy and Mitochondria Dysfunction in Human Glioma U251 Cells Toxicol. Sci., August 1, 2009; 110(2): 376 - 388. [Abstract] [Full Text] [PDF]

				L. ANNOVAZZI, M. MELLAI, V. CALDERA, G. VALENTE, L. TESSITORE, and D. SCHIFFER mTOR, S6 and AKT Expression in Relation to Proliferation and Apoptosis/Autophagy in Glioma Anticancer Res, August 1, 2009; 29(8): 3087 - 3094. [Abstract] [Full Text] [PDF]

				T.-J. Liu, D. Koul, T. LaFortune, N. Tiao, R. J. Shen, S.-M. Maira, C. Garcia-Echevrria, and W.K. A. Yung NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas Mol. Cancer Ther., August 1, 2009; 8(8): 2204 - 2210. [Abstract] [Full Text] [PDF]

				M. W. Ronellenfitsch, D. P. Brucker, M. C. Burger, S. Wolking, F. Tritschler, J. Rieger, W. Wick, M. Weller, and J. P. Steinbach Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death Brain, June 1, 2009; 132(6): 1509 - 1522. [Abstract] [Full Text] [PDF]

				W. Zhuang, Z. Qin, and Z. Liang The role of autophagy in sensitizing malignant glioma cells to radiation therapy Acta Biochim Biophys Sin, May 1, 2009; 41(5): 341 - 351. [Abstract] [Full Text] [PDF]

				C. Y. Zou, K. D. Smith, Q.-S. Zhu, J. Liu, I. E. McCutcheon, J. M. Slopis, F. Meric-Bernstam, Z. Peng, W. G. Bornmann, G. B. Mills, et al. Dual targeting of AKT and mammalian target of rapamycin: A potential therapeutic approach for malignant peripheral nerve sheath tumor Mol. Cancer Ther., May 1, 2009; 8(5): 1157 - 1168. [Abstract] [Full Text] [PDF]

				A. Bommareddy, E.-R. Hahm, D. Xiao, A. A. Powolny, A. L. Fisher, Y. Jiang, and S. V. Singh Atg5 Regulates Phenethyl Isothiocyanate-Induced Autophagic and Apoptotic Cell Death in Human Prostate Cancer Cells Cancer Res., April 15, 2009; 69(8): 3704 - 3712. [Abstract] [Full Text] [PDF]

				M. Breuleux, M. Klopfenstein, C. Stephan, C. A. Doughty, L. Barys, S.-M. Maira, D. Kwiatkowski, and H. A. Lane Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition Mol. Cancer Ther., April 1, 2009; 8(4): 742 - 753. [Abstract] [Full Text] [PDF]

				C. C. Thoreen, S. A. Kang, J. W. Chang, Q. Liu, J. Zhang, Y. Gao, L. J. Reichling, T. Sim, D. M. Sabatini, and N. S. Gray An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1 J. Biol. Chem., March 20, 2009; 284(12): 8023 - 8032. [Abstract] [Full Text] [PDF]

				V. L. Crotzer and J. S. Blum Autophagy and Its Role in MHC-Mediated Antigen Presentation J. Immunol., March 15, 2009; 182(6): 3335 - 3341. [Abstract] [Full Text] [PDF]

				M. Marinov, A. Ziogas, O. E. Pardo, L. T. Tan, T. Dhillon, F. A. Mauri, H. A. Lane, N. R. Lemoine, U. Zangemeister-Wittke, M. J. Seckl, et al. AKT/mTOR Pathway Activation and BCL-2 Family Proteins Modulate the Sensitivity of Human Small Cell Lung Cancer Cells to RAD001 Clin. Cancer Res., February 15, 2009; 15(4): 1277 - 1287. [Abstract] [Full Text] [PDF]

				M. Gao, P. Y. Yeh, Y.-S. Lu, C.-H. Hsu, K.-F. Chen, W.-C. Lee, W.-C. Feng, C.-S. Chen, M.-L. Kuo, and A.-L. Cheng OSU-03012, a Novel Celecoxib Derivative, Induces Reactive Oxygen Species-Related Autophagy in Hepatocellular Carcinoma Cancer Res., November 15, 2008; 68(22): 9348 - 9357. [Abstract] [Full Text] [PDF]

				M. Degtyarev, A. De Maziere, C. Orr, J. Lin, B. B. Lee, J. Y. Tien, W. W. Prior, S. van Dijk, H. Wu, D. C. Gray, et al. Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents J. Cell Biol., October 6, 2008; 183(1): 101 - 116. [Abstract] [Full Text] [PDF]

				H. Roca, Z. Varsos, and K. J. Pienta CCL2 Protects Prostate Cancer PC3 Cells from Autophagic Death via Phosphatidylinositol 3-Kinase/AKT-dependent Survivin Up-regulation J. Biol. Chem., September 5, 2008; 283(36): 25057 - 25073. [Abstract] [Full Text] [PDF]

				T. Pan, S. Kondo, W. Le, and J. Jankovic The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease Brain, August 1, 2008; 131(8): 1969 - 1978. [Abstract] [Full Text] [PDF]

				M. Wang, W. Tan, J. Zhou, J. Leow, M. Go, H. S. Lee, and P. J. Casey A Small Molecule Inhibitor of Isoprenylcysteine Carboxymethyltransferase Induces Autophagic Cell Death in PC3 Prostate Cancer Cells J. Biol. Chem., July 4, 2008; 283(27): 18678 - 18684. [Abstract] [Full Text] [PDF]

				J. H. Overmeyer, A. Kaul, E. E. Johnson, and W. A. Maltese Active Ras Triggers Death in Glioblastoma Cells through Hyperstimulation of Macropinocytosis Mol. Cancer Res., June 1, 2008; 6(6): 965 - 977. [Abstract] [Full Text] [PDF]

				R. A. Newman, Y. Kondo, T. Yokoyama, S. Dixon, C. Cartwright, D. Chan, M. Johansen, and Peiying Yang Autophagic Cell Death of Human Pancreatic Tumor Cells Mediated by Oleandrin, a Lipid-Soluble Cardiac Glycoside Integr Cancer Ther, December 1, 2007; 6(4): 354 - 364. [Abstract] [PDF]

				X. Q. Lun, H. Zhou, T. Alain, B. Sun, L. Wang, J. W. Barrett, M. M. Stanford, G. McFadden, J. Bell, D. L. Senger, et al. Targeting Human Medulloblastoma: Oncolytic Virotherapy with Myxoma Virus Is Enhanced by Rapamycin Cancer Res., September 15, 2007; 67(18): 8818 - 8827. [Abstract] [Full Text] [PDF]

				H. Aoki, E. Iwado, M. S. Eller, Y. Kondo, K. Fujiwara, G.-Z. Li, K. R. Hess, D. R. Siwak, R. Sawaya, G. B. Mills, et al. Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells FASEB J, September 1, 2007; 21(11): 2918 - 2930. [Abstract] [Full Text] [PDF]

				A M Lobascio, F G Klinger, M L Scaldaferri, D Farini, and M De Felici Analysis of programmed cell death in mouse fetal oocytes Reproduction, August 1, 2007; 134(2): 241 - 252. [Abstract] [Full Text] [PDF]

				S. Ohtani, A. Iwamaru, W. Deng, K. Ueda, G. Wu, G. Jayachandran, S. Kondo, E. N. Atkinson, J. D. Minna, J. A. Roth, et al. Tumor Suppressor 101F6 and Ascorbate Synergistically and Selectively Inhibit Non-Small Cell Lung Cancer Growth by Caspase-Independent Apoptosis and Autophagy Cancer Res., July 1, 2007; 67(13): 6293 - 6303. [Abstract] [Full Text] [PDF]

				H. Aoki, Y. Takada, S. Kondo, R. Sawaya, B. B. Aggarwal, and Y. Kondo Evidence That Curcumin Suppresses the Growth of Malignant Gliomas in Vitro and in Vivo through Induction of Autophagy: Role of Akt and Extracellular Signal-Regulated Kinase Signaling Pathways Mol. Pharmacol., July 1, 2007; 72(1): 29 - 39. [Abstract] [Full Text] [PDF]

				E. F. Petricoin III, V. Espina, R. P. Araujo, B. Midura, C. Yeung, X. Wan, G. S. Eichler, D. J. Johann Jr., S. Qualman, M. Tsokos, et al. Phosphoprotein Pathway Mapping: Akt/Mammalian Target of Rapamycin Activation Is Negatively Associated with Childhood Rhabdomyosarcoma Survival Cancer Res., April 1, 2007; 67(7): 3431 - 3440. [Abstract] [Full Text] [PDF]

				U. Akar, B. Ozpolat, K. Mehta, J. Fok, Y. Kondo, and G. Lopez-Berestein Tissue Transglutaminase Inhibits Autophagy in Pancreatic Cancer Cells Mol. Cancer Res., March 1, 2007; 5(3): 241 - 249. [Abstract] [Full Text] [PDF]

				A. Iwamaru, E. Iwado, S. Kondo, R. A. Newman, B. Vera, A. D. Rodriguez, and Y. Kondo Eupalmerin acetate, a novel anticancer agent from Caribbean gorgonian octocorals, induces apoptosis in malignant glioma cells via the c-Jun NH2-terminal kinase pathway Mol. Cancer Ther., January 1, 2007; 6(1): 184 - 192. [Abstract] [Full Text] [PDF]

				D. Kessel, J. J. Reiners Jr., S. T. Hazeldine, L. Polin, and J. P. Horwitz The role of autophagy in the death of L1210 leukemia cells initiated by the new antitumor agents, XK469 and SH80 Mol. Cancer Ther., January 1, 2007; 6(1): 370 - 379. [Abstract] [Full Text] [PDF]

				P.-L. Kuo, Y.-L. Hsu, and C.-Y. Cho Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells Mol. Cancer Ther., December 1, 2006; 5(12): 3209 - 3221. [Abstract] [Full Text] [PDF]

				C. Cao, T. Subhawong, J. M. Albert, K. W. Kim, L. Geng, K. R. Sekhar, Y. J. Gi, and B. Lu Inhibition of Mammalian Target of Rapamycin or Apoptotic Pathway Induces Autophagy and Radiosensitizes PTEN Null Prostate Cancer Cells. Cancer Res., October 15, 2006; 66(20): 10040 - 10047. [Abstract] [Full Text] [PDF]

				A. Herman-Antosiewicz, D. E. Johnson, and S. V. Singh Sulforaphane Causes Autophagy to Inhibit Release of Cytochrome c and Apoptosis in Human Prostate Cancer Cells Cancer Res., June 1, 2006; 66(11): 5828 - 5835. [Abstract] [Full Text] [PDF]

				H. Ito, H. Aoki, F. Kuhnel, Y. Kondo, S. Kubicka, T. Wirth, E. Iwado, A. Iwamaru, K. Fujiwara, K. R. Hess, et al. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus. J Natl Cancer Inst, May 3, 2006; 98(9): 625 - 636. [Abstract] [Full Text] [PDF]

				W. N. Hait, S. Jin, and J.-M. Yang A Matter of Life or Death (or Both): Understanding Autophagy in Cancer. Clin. Cancer Res., April 1, 2006; 12(7): 1961 - 1965. [Full Text] [PDF]

				H. Wu, J.-M. Yang, S. Jin, H. Zhang, and W. N. Hait Elongation factor-2 kinase regulates autophagy in human glioblastoma cells. Cancer Res., March 15, 2006; 66(6): 3015 - 3023. [Abstract] [Full Text] [PDF]

				X. Zeng, J. H. Overmeyer, and W. A. Maltese Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking J. Cell Sci., January 15, 2006; 119(2): 259 - 270. [Abstract] [Full Text] [PDF]

				S. Han, F. R. Khuri, and J. Roman Fibronectin Stimulates Non-Small Cell Lung Carcinoma Cell Growth through Activation of Akt/Mammalian Target of Rapamycin/S6 Kinase and Inactivation of LKB1/AMP-Activated Protein Kinase Signal Pathways Cancer Res., January 1, 2006; 66(1): 315 - 323. [Abstract] [Full Text] [PDF]